Dr. Nicole Bentley, MD
Claim this profileUniversity of Alabama at Birmingham
Studies Parkinson's Disease
Studies Movement Disorders
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Nicole Bentley, MD is currently running
Deep Brain Stimulation
for Movement Disorders
The purpose of this study is to investigate the brain activity associated with motor and non-motor symptoms of movement disorders, including Parkinson's disease (PD) and essential tremor. These movement disorders commonly have significant non-motor features, such as depression, cognitive and memory impairment, decreased attention, speech and language disturbances, and slower processing speeds. The investigators are interested in the brain activity associated with these motor and non-motor symptoms, and propose to investigate changes in brain activity while the investigators perform recordings of the surface and deep structures of the brain, in addition to the typical recordings the investigators perform, during routine deep brain stimulation (DBS) surgery.
Recruiting1 award N/A4 criteria
Deep Brain Stimulation
for Parkinson's Disease
The purpose of this study is to investigate the brain activity associated with non-motor symptoms of movement disorders, including Parkinson's disease and essential tremor. These movement disorders commonly have significant non-motor features also, including depression, cognitive impairment, decreased attention, and slower processing speeds. The investigators are interested in the brain activity associated with these symptoms, and perform recordings of the surface of the brain, in addition to the typical recordings the investigators perform, during routine deep brain stimulation (DBS) surgery.
Recruiting1 award N/A4 criteria
More about Nicole Bentley, MD
Clinical Trial Related6 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Nicole Bentley, MD has experience with
- Deep Brain Stimulation
- Response Inhibition
- Response Inhibition And Deep Brain Stimulation
Breakdown of trials Nicole Bentley, MD has run
Parkinson's Disease
Movement Disorders
Functional Movement Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nicole Bentley, MD specialize in?
Nicole Bentley, MD focuses on Parkinson's Disease and Movement Disorders. In particular, much of their work with Parkinson's Disease has involved treating patients, or patients who are undergoing treatment.
Is Nicole Bentley, MD currently recruiting for clinical trials?
Yes, Nicole Bentley, MD is currently recruiting for 2 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Nicole Bentley, MD has studied deeply?
Yes, Nicole Bentley, MD has studied treatments such as Deep Brain Stimulation, Response Inhibition, Response Inhibition and Deep Brain Stimulation.
What is the best way to schedule an appointment with Nicole Bentley, MD?
Apply for one of the trials that Nicole Bentley, MD is conducting.
What is the office address of Nicole Bentley, MD?
The office of Nicole Bentley, MD is located at: University of Alabama at Birmingham, Birmingham, Alabama 35233 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.